
Isaac Shomer
Examiner (ID: 6801, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1378 |
| Issued Applications | 769 |
| Pending Applications | 144 |
| Abandoned Applications | 506 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18792743
[patent_doc_number] => 11826477
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-28
[patent_title] => Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment
[patent_app_type] => utility
[patent_app_number] => 17/842876
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 14721
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842876 | Metal organic framework/porous silicate and/or aluminosilicate nanocarrier for blastocystosis treatment | Jun 16, 2022 | Issued |
Array
(
[id] => 19563485
[patent_doc_number] => 12138235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Cape-loaded targeted microvesicular cancer drug and method for developing the same
[patent_app_type] => utility
[patent_app_number] => 17/840700
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3373
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840700 | Cape-loaded targeted microvesicular cancer drug and method for developing the same | Jun 14, 2022 | Issued |
Array
(
[id] => 19462312
[patent_doc_number] => 20240315981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => SUB-MICRON PARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/570611
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570611 | SUB-MICRON PARTICLE | Jun 13, 2022 | Pending |
Array
(
[id] => 18829618
[patent_doc_number] => 20230398142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => METHOD FOR PREVENTING OR TREATING UROLOGICAL CHRONIC PELVIC PAIN SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/835634
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835634
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835634 | Method for preventing or treating urological chronic pelvic pain syndrome | Jun 7, 2022 | Issued |
Array
(
[id] => 18034520
[patent_doc_number] => 20220378735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => CABAZITAXEL WEAKLY- ALKALINE DERIVATIVE AND FORMULATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/831962
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831962 | CABAZITAXEL WEAKLY- ALKALINE DERIVATIVE AND FORMULATION THEREOF | Jun 2, 2022 | Pending |
Array
(
[id] => 18237870
[patent_doc_number] => 20230070180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => PROTEIN-LOADED PLGA NANOSPHERES
[patent_app_type] => utility
[patent_app_number] => 17/830615
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830615 | Protein-loaded PLGA nanospheres | Jun 1, 2022 | Issued |
Array
(
[id] => 17895468
[patent_doc_number] => 20220305130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => PROCESS FOR FORMULATING AN ANIONIC AGENT
[patent_app_type] => utility
[patent_app_number] => 17/831258
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831258 | PROCESS FOR FORMULATING AN ANIONIC AGENT | Jun 1, 2022 | Abandoned |
Array
(
[id] => 18283323
[patent_doc_number] => 20230098795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DELIVERY OF AGENTS USING METASTABLE LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 17/829960
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829960 | Delivery of agents using metastable liposomes | May 31, 2022 | Issued |
Array
(
[id] => 19586286
[patent_doc_number] => 20240383843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => MC3-Type Lipids
[patent_app_type] => utility
[patent_app_number] => 18/564754
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564754
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564754 | MC3-Type Lipids | May 25, 2022 | Pending |
Array
(
[id] => 18762977
[patent_doc_number] => 11813357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Treatment of hip pain with sustained-release liposomal anesthetic compositions
[patent_app_type] => utility
[patent_app_number] => 17/746249
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22340
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746249 | Treatment of hip pain with sustained-release liposomal anesthetic compositions | May 16, 2022 | Issued |
Array
(
[id] => 19402297
[patent_doc_number] => 20240285808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
[patent_app_type] => utility
[patent_app_number] => 18/290135
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290135
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/290135 | MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES | May 12, 2022 | Pending |
Array
(
[id] => 17828231
[patent_doc_number] => 20220265535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Core Shell Silica Particles and Uses Thereof As an Anti-Bacterial Agent
[patent_app_type] => utility
[patent_app_number] => 17/740426
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740426 | Core shell silica particles and uses thereof as an anti-bacterial agent | May 9, 2022 | Issued |
Array
(
[id] => 19477479
[patent_doc_number] => 20240325521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => IONIZABLE LIPID COMPOUND FOR NUCLEIC ACID DELIVERY AND LNP COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/576244
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18576244
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/576244 | IONIZABLE LIPID COMPOUND FOR NUCLEIC ACID DELIVERY AND LNP COMPOSITION THEREOF | May 9, 2022 | Pending |
Array
(
[id] => 18165872
[patent_doc_number] => 20230032473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => NAD(H) NANOPARTICLES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/741298
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741298
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741298 | NAD(H) NANOPARTICLES AND METHODS OF USE | May 9, 2022 | Abandoned |
Array
(
[id] => 20592464
[patent_doc_number] => 12576160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Bispecific nanoparticle systems for targeting cancer cells
[patent_app_type] => utility
[patent_app_number] => 18/547664
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 70
[patent_no_of_words] => 15824
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547664
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547664 | Bispecific nanoparticle systems for targeting cancer cells | May 5, 2022 | Issued |
Array
(
[id] => 18257892
[patent_doc_number] => 20230084932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS OF IMPROVING THE SOLUBILITY AND BIOAVAILABILITY OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/727993
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727993 | Methods of improving the solubility and bioavailability of therapeutic agents | Apr 24, 2022 | Issued |
Array
(
[id] => 19186131
[patent_doc_number] => 20240165044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => LIPID NANOPARTICLE PREPARATION METHOD AND PREPARATION APPARATUS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/281915
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18281915
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/281915 | LIPID NANOPARTICLE PREPARATION METHOD AND PREPARATION APPARATUS THEREFOR | Apr 21, 2022 | Pending |
Array
(
[id] => 19216319
[patent_doc_number] => 20240181023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/556287
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556287
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556287 | FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS | Apr 20, 2022 | Pending |
Array
(
[id] => 18628174
[patent_doc_number] => 20230287020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => AMPHIPHILIC MATERIAL AND APPLICATION THEREOF IN PREPARATION FOR LIPOSOME
[patent_app_type] => utility
[patent_app_number] => 18/021613
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021613 | Amphiphilic material and application thereof in preparation for liposome | Apr 19, 2022 | Issued |
Array
(
[id] => 19246790
[patent_doc_number] => 20240197774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
[patent_app_type] => utility
[patent_app_number] => 18/287009
[patent_app_country] => US
[patent_app_date] => 2022-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287009
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287009 | Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles | Apr 15, 2022 | Pending |